Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia-Reference-Cited by-同舟云学术

Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia

Published:2013-12 Issue:12 Volume:112 Page:1885-1895
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Bays Harold E.,Averna Maurizio,Majul Claudio,Muller-Wieland Dirk,De Pellegrin Annamaria,Giezek Hilde,Lee Raymond,Lowe Robert S.,Brudi Philippe,Triscari Joseph,Farnier Michel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Catapano;Atherosclerosis,2011

2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines;Grundy;J Am Coll Cardiol,2004

3. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

4. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the National Heart, Lung, and Blood Institute;Smith;J Am Coll Cardiol,2006

5. Multiple Imputation for Nonresponse in Surveys;Rubin,1987

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Lowering Therapy in the Elderly;Journal of the American College of Cardiology;2023-04

2. Lipid-Lowering Efficacy of Combination Therapy With Moderate-Intensity Statin and Ezetimibe Versus High-Intensity Statin Monotherapy: A Randomized, Open-Label, Non-Inferiority Trial From Korea;Journal of Lipid and Atherosclerosis;2023

3. Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape;European Heart Journal;2022-09-14

4. Lowering LDL cholesterol in clinical practice: time for change?;The Lancet;2022-07

5. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis;Current Atherosclerosis Reports;2022-04-30